Combining TKIs with checkpoint inhibitors for prostate cancer – is this the way forward?
CheckMate 171: Phase 2 trial of nivolumab for advanced squamous cell non-small cell lung cancer
Heating up a tumor: modulating the immunoscore
Results of KEYNOTE-024 trial of pembrolizumab in NSCLC
Current treatment landscape for neuroendocrine tumors